Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Brigid Boland

    TitleAssistant Adjunct Professor
    SchoolUniversity of California, San Diego
    AddressUCSD Medical Center, MC0956, 9452 Medical Center Dr.
    CA La Jolla 92037
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      Advanced Fellowship2015UC San Diego
      Fellowship2013UC San Diego
      Residency2010UC San Diego Physician-Scientist Training Program
      MD2008UC San Francisco School of Medicine
      BS2003Yale University
      Collapse Awards and Honors
      UCSD2017  - 2019KL2
      CCFA2015  - 2018Career Development Award
      AGA2017Future Leader
      CCFA San Diego/Riverside 2017Top 50 in 50 years

      Collapse Overview 

      Collapse Research 
      Collapse Research Activities and Funding
      Identifying Biomarkers Predictive of Clinical and Endoscopic Response to Vedolizumab in Inflammatory Bowel Disease
      NIH 1KL2TR001444Jan 1, 2017
      Identifying Biomarkers Predictive of Clinical and Endoscopic Response to Vedolizumab in Inflammatory Bowel Disease
      CCFA Career Development AwardOct 1, 2015 - Sep 30, 2018

      Collapse ORNG Applications 
      Collapse Featured Publications
      Collapse Websites
      Collapse Faculty Mentoring

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Singh S, George J, Boland B, Vande Casteele N, Sandborn WJ. Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis. J Crohns Colitis. 2018 Jan 23. PMID: 29370397.
        View in: PubMed
      2. Boland B, Vermeire S. Janus Kinase Antagonists and Other Novel Small Molecules for the Treatment of Crohn's Disease. Gastroenterol Clin North Am. 2017 Sep; 46(3):627-644. PMID: 28838419.
        View in: PubMed
      3. Boland B, Shergill A, Kaltenbach T. Endoscopic Surveillance in Long-standing Colitis. Curr Treat Options Gastroenterol. 2017 Aug 12. PMID: 28803403.
        View in: PubMed
      4. Bertin S, Aoki-Nonaka Y, Lee J, de Jong PR, Kim P, Han T, Yu T, To K, Takahashi N, Boland B, Chang JT, Ho SB, Herdman S, Corr M, Franco A, Sharma S, Dong H, Akopian AN, Raz E. The TRPA1 ion channel is expressed in CD4+ T cells and restrains T-cell-mediated colitis through inhibition of TRPV1. Gut. 2017 Sep; 66(9):1584-1596. PMID: 27325418.
        View in: PubMed
      5. Dulai PS, Singh S, Jiang X, Peerani F, Narula N, Chaudrey K, Whitehead D, Hudesman D, Lukin D, Swaminath A, Shmidt E, Wang S, Boland B, Chang JT, Kane S, Siegel CA, Loftus EV, Sandborn WJ, Sands BE, Colombel JF. The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium. Am J Gastroenterol. 2016 Aug; 111(8):1147-55. PMID: 27296941.
        View in: PubMed
      6. Boland B, Bagi P, Valasek MA, Chang JT, Bustamante R, Madlensky L, Sandborn WJ, Harismendy O, Gupta S. Cronkhite Canada Syndrome: Significant Response to Infliximab and a Possible Clue to Pathogenesis. Am J Gastroenterol. 2016 May; 111(5):746-8. PMID: 27151126.
        View in: PubMed
      7. Dulai PS, Singh S, Casteele NV, Boland B, Sandborn WJ. How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 Apr; 22(4):998-1009. PMID: 26835982.
        View in: PubMed
      8. Boland B, Dulai PS, Chang M, Sandborn WJ, Levesque BG. Pseudomonas Meningitis During Vedolizumab Therapy for Crohn's Disease. Am J Gastroenterol. 2015 Nov; 110(11):1631-2. PMID: 26618431.
        View in: PubMed
      9. Taniguchi K, Wu LW, Grivennikov SI, de Jong PR, Lian I, Yu FX, Wang K, Ho SB, Boland B, Chang JT, Sandborn WJ, Hardiman G, Raz E, Maehara Y, Yoshimura A, Zucman-Rossi J, Guan KL, Karin M. A gp130-Src-YAP module links inflammation to epithelial regeneration. Nature. 2015 Mar 05; 519(7541):57-62. PMID: 25731159; PMCID: PMC4447318.
      10. Boland B, Widjaja CE, Banno A, Zhang B, Kim SH, Stoven S, Peterson MR, Jones MC, Su HI, Crowe SE, Bui JD, Ho SB, Okugawa Y, Goel A, Marietta EV, Khosroheidari M, Jepsen K, Aramburu J, López-Rodríguez C, Sandborn WJ, Murray JA, Harismendy O, Chang JT. Immunodeficiency and autoimmune enterocolopathy linked to NFAT5 haploinsufficiency. J Immunol. 2015 Mar 15; 194(6):2551-60. PMID: 25667416; PMCID: PMC4355235.
      11. Boland B, Boyle DL, Sandborn WJ, Firestein GS, Levesque BG, Hillman J, Zhang B, Proudfoot J, Eckmann L, Ernst PB, Rivera-Nieves J, Pola S, Copur-Dahi N, Zou G, Chang JT. Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's disease. Inflamm Bowel Dis. 2015 Feb; 21(2):323-30. PMID: 25545378; PMCID: PMC4404151.
      12. Boland B, Boyle DL, Sandborn WJ, Firestein GS, Levesque BG, Hillman J, Zhang B, Proudfoot J, Eckmann L, Ernst PB, Rivera-Nieves J, Pola S, Copur-Dahi N, Chang JT. Validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitis. Aliment Pharmacol Ther. 2014 Sep; 40(5):477-85. PMID: 25041724; PMCID: PMC4143528.
      13. Boland B, Sandborn WJ, Chang JT. Update on Janus kinase antagonists in inflammatory bowel disease. Gastroenterol Clin North Am. 2014 Sep; 43(3):603-17. PMID: 25110261; PMCID: PMC4129380.
      14. Boland B, Rivera-Nieves J, Gupta S. Lower endoscopy and prevention of colon cancer. Gastroenterology. 2014 Jul; 147(1):245-6. PMID: 24866428.
        View in: PubMed
      15. Zhang B, Copur-Dahi N, Kalmaz D, Boland B. Gastrointestinal manifestations of breast cancer metastasis. Dig Dis Sci. 2014 Sep; 59(9):2344-6. PMID: 24748230.
        View in: PubMed
      16. Pola S, Boland B, Lin GY, Kuo A, Sandborn WJ. Non-cirrhotic portal hypertension due to 6-mercaptopurine use for Crohn's disease. Dig Dis Sci. 2014 Jul; 59(7):1642-4. PMID: 24535249.
        View in: PubMed
      17. Boland B, Dong MH, Bettencourt R, Barrett-Connor E, Loomba R. Association of serum bilirubin with aging and mortality. J Clin Exp Hepatol. 2014 Mar; 4(1):1-7. PMID: 25328328; PMCID: PMC4017193.
      18. Boland B, Edelman SV, Wolosin JD. Gastrointestinal complications of diabetes. Endocrinol Metab Clin North Am. 2013 Dec; 42(4):809-32. PMID: 24286951.
        View in: PubMed
      19. Montandon M, Sahin-Hodoglugil NN, Bukusi E, Agot K, Boland B, Cohen CR. Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya. Sex Health. 2008 Dec; 5(4):339-46. PMID: 19061553.
        View in: PubMed
      20. Ndhlovu LC, Chapman JM, Jha AR, Snyder-Cappione JE, Pagán M, Leal FE, Boland B, Norris PJ, Rosenberg MG, Nixon DF. Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection. AIDS. 2008 May 11; 22(8):990-2. PMID: 18453860; PMCID: PMC2850608.
      21. Fonder MA, Sacco KA, Termine A, Boland B, Seyal AA, Dudas MM, Vessicchio JC, George TP. Smoking cue reactivity in schizophrenia: effects of a nicotinic receptor antagonist. Biol Psychiatry. 2005 Apr 01; 57(7):802-8. PMID: 15820238.
        View in: PubMed